"Reduce Oncology Trial Delays from Study Start-Up to Patient Recruitment" is an upcoming free webinar hosted by Xtalks, taking place on 7 October at 10:00 am EDT (4:00 pm CEST / EU-Central).

The discussion will explore how earlier site engagement, stronger feasibility and effective patient identification can help Sponsors and CROs reduce avoidable delays in complex oncology trials.

The featured speakers will discuss site selection, pre-screening and patient identification for biomarker-driven studies, including differences between Phase I and later-phase recruitment. Attendees will also explore how referral pathways, site capabilities and regional differences across the US and Europe can affect enrollment planning.

TORONTO, Sept. 18, 2026 /PRNewswire/ -- Complex oncology trials put pressure on every stage of study execution, from selecting and preparing the right sites to finding eligible patients in increasingly specific populations.

What can sponsors and CROs do to reduce avoidable delays and make recruitment more predictable? In this webinar, the featured speakers will explore how early site engagement and stronger feasibility can improve site selection, uncover operational barriers sooner and support successful enrollment across early- and late-phase oncology studies.

As oncology trials become more biomarker-driven and patient populations harder to identify, effective pre-screening and patient identification are becoming increasingly important. The discussion will examine approaches for finding patients with specific genetic mutations and consider how referral pathways and site capabilities influence recruitment.

Patient recruitment requirements can also differ significantly across phases of development. The webinar will explore how patient identification, referral pathways and site capabilities can vary between Phase I and later-phase studies, helping sponsors and CROs consider these differences when planning recruitment strategies. The discussion will also compare the practical realities of running oncology trials across the US and Europe.

Register for this webinar to learn how patient recruitment strategies can improve patient identification, site readiness and enrollment across complex oncology trials.

Join Chloe Rose, PhD, Vice President, Site Solutions, Pratia; Julio Peguero, MD, Medical Oncologist; President and Executive Chairman, P1 Pratia Oncology; Santiago Viteri, MD, PhD, Medical Oncologist; CEO, Pratia Sirius; and Lauren Stockwell

Associate Director, Education & Engagement, SCRS, for the live webinar on Wednesday, October 7, 2026, at 10am EDT (4pm CEST / EU-Central).

For more information, or to register for this event, visit Reduce Oncology Trial Delays from Study Start-Up to Patient Recruitment.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: skumar@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/what-does-it-take-to-set-a-complex-oncology-trial-up-for-success-before-the-first-patient-is-screened-join-pratia-and-industry-experts-for-a-practical-discussion-on-reducing-delays-from-study-start-up-to-patient-recruitment-302882405.html

SOURCE Xtalks